These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 2119673)
1. [rt-PA in extracardiac thromboembolic vascular occlusions]. Cortellaro M; Cofrancesco E; Polli EE Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673 [TBL] [Abstract][Full Text] [Related]
2. [Local thrombolysis in peripheral arterial occlusion]. Hess H Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076 [TBL] [Abstract][Full Text] [Related]
3. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
4. Studies on the medical treatment of deep vein thrombosis. Schulman S Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282 [TBL] [Abstract][Full Text] [Related]
5. Thrombolytic treatment of acute pulmonary embolism. Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388 [TBL] [Abstract][Full Text] [Related]
6. Thrombolysis in newborns and infants. Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499 [TBL] [Abstract][Full Text] [Related]
7. [Thrombolytic therapy of deep venous thrombosis with rt-PA]. Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342 [TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism. Carter BL; Jones ME; Waickman LA Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic use of thrombolytic agents. Stambaugh RL; Alexander MR Am J Hosp Pharm; 1981 Jun; 38(6):817-24. PubMed ID: 7018230 [TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator. Zimmerman R; Gürsoy A; Horn A; Harenberg J; Diehm C; Kübler W Semin Thromb Hemost; 1991 Jan; 17(1):48-54. PubMed ID: 1904629 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model. Collen D; Stassen JM; De Cock F Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288 [TBL] [Abstract][Full Text] [Related]
13. [Actual state of thrombolytic treatment of recent vein thrombosis and pulmonary embolism (author's transl)]. Verstraete M J Mal Vasc; 1981; 6(4):251-6. PubMed ID: 7198677 [TBL] [Abstract][Full Text] [Related]
15. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog. Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384 [TBL] [Abstract][Full Text] [Related]
16. [The treatment of deep venous thrombosis. Thrombolysis vs heparin]. Schmutzler R Phlebologie; 1990; 43(4):656-65; discussion 666. PubMed ID: 2093922 [TBL] [Abstract][Full Text] [Related]